LONGEVERON
Live / Registered — Registered (as of 05 Mar 2024)
What this means for you
Registered since 05 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88295768
- Registration number
- 7322945
- Mark type
- Stylized text
- Filed
- 11 Feb 2019
- Published for opposition
- 04 Jun 2019
- Registered
- 05 Mar 2024
- Attorney of record
- Bryce J. Maynard
Goods and services
- Class 001 — Chemicals: Stem cells for research or scientific purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving stem cells for medical purposes
Owner
- LONGEVERON INC., WILMINGTON, DE, US
- LONGEVERON INC., WILMINGTON, DE, US
- Longeveron LLC, Miami, FL, US
- Longeveron LLC, Miami, FL, US
Prosecution history
- 05 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 01 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jan 2024 — ASSIGNED TO LIE
- 08 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jun 2023 — NON-FINAL ACTION E-MAILED
- 08 Jun 2023 — SU - NON-FINAL ACTION - WRITTEN
- 18 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 May 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 Apr 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED